AKERO THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.8 USD | -1.05% |
|
+5.53% | -10.92% |
| Apr. 30 | Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer | CI |
| Mar. 08 | Akero Therapeutics Raises $367 Million From Share Offering | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AKERO THERAPEUTICS, INC. | Bio Therapeutic Drugs | -1.05% | +5.53% | -10.92% | -57.68% | - | 1.45B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- AKRO Stock
- Charts Akero Therapeutics, Inc.
- Comparison Chart